XML 23 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements Of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period Of Adoption, Adjustment
Total  Synopsys Stockholders’ Equity
Total  Synopsys Stockholders’ Equity
Cumulative Effect, Period Of Adoption, Adjustment
Common Stock
Capital in Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjustment
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning Balance (in shares) at Oct. 31, 2020         152,618            
Beginning balance at Oct. 31, 2020 $ 4,912,367   $ 4,907,404   $ 1,528 $ 1,653,166 $ 3,795,397   $ (488,613) $ (54,074) $ 4,963
Beginning balance (Adjustment Due To Adoption Of Accounting Standards Related To Credit Losses) at Oct. 31, 2020   $ (3,200)   $ (3,200)       $ (3,200)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 756,359   757,516       757,516       (1,157)
Other comprehensive income (loss), net of tax effects $ 4,470   4,470             4,470  
Purchases of treasury stock (in shares) (2,780)       (2,780)            
Purchases of treasury stock $ (753,081)   (753,081)   $ (28) 28     (753,081)    
Equity forward contract, net $ (35,000)   (35,000)     (35,000)          
Common stock issued, net of shares withheld for employee taxes (in shares) 3,224       3,224            
Common stock issued, net of shares withheld for employee taxes $ 71,756   71,756   $ 31 (387,103)     458,828    
Stock-based compensation 345,272   345,272     345,272          
Ending Balance (in shares) at Oct. 31, 2021         153,062            
Ending balance at Oct. 31, 2021 5,298,943   5,295,137   $ 1,531 1,576,363 4,549,713   (782,866) (49,604) 3,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 983,288   984,594       984,594       (1,306)
Other comprehensive income (loss), net of tax effects $ (184,673)   (184,673)             (184,673)  
Purchases of treasury stock (in shares) (3,609)       (3,609)            
Purchases of treasury stock $ (1,135,000)   (1,135,000)   $ (36) 36     (1,135,000)    
Equity forward contract, net $ 35,000   35,000     35,000          
Common stock issued, net of shares withheld for employee taxes (in shares) 2,922       2,922            
Common stock issued, net of shares withheld for employee taxes $ 63,939   63,939   $ 29 (581,001)     644,911    
Stock-based compensation $ 459,029   456,728     456,728         2,301
Ending Balance (in shares) at Oct. 31, 2022 152,375       152,375            
Ending balance at Oct. 31, 2022 $ 5,520,526   5,515,725   $ 1,524 1,487,126 5,534,307   (1,272,955) (234,277) 4,801
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 1,228,127   1,229,888       1,229,888       (1,761)
Other comprehensive income (loss), net of tax effects $ 37,863   37,863             37,863  
Purchases of treasury stock (in shares) (2,992)       (2,992)            
Purchases of treasury stock $ (1,160,724)   (1,160,724)   $ (30) 30     (1,160,724)    
Equity forward contract, net $ (45,000)   (45,000)     (45,000)          
Common stock issued, net of shares withheld for employee taxes (in shares) 2,670       2,670            
Common stock issued, net of shares withheld for employee taxes $ 13,737   13,737   $ 27 (725,211) (19,108)   758,029    
Stock-based compensation 563,292   558,078     558,078         5,214
Adjustments to redeemable non-controlling interest (3,388)   (3,388)       (3,388)        
Recognition of non-controlling interest upon issuance of subsidiary stock $ (1,175)   1,129     1,129         (2,304)
Ending Balance (in shares) at Oct. 31, 2023 152,053       152,053            
Ending balance at Oct. 31, 2023 $ 6,153,258   $ 6,147,308   $ 1,521 $ 1,276,152 $ 6,741,699   $ (1,675,650) $ (196,414) $ 5,950